SCEL antisense RNA 1 (non-protein coding) (SCEL-AS1)

SCEL antisense RNA 1 (SCEL-AS1) is a long non-coding RNA classified as an antisense RNA because it is transcribed from the opposite DNA strand relative to the SCEL gene. Antisense RNAs, particularly lncRNA forms, primarily function as regulators of gene expression, often by pairing with their sense mRNA or influencing epigenetic states through recruitment of chromatin modifiers or other regulatory proteins[1][4]. While antisense RNA molecules have been implicated in diverse cellular processes—including gene silencing, fine-tuning transcription levels, and epigenetic gene regulation—there is currently no evidence that SCEL-AS1 acts as a direct therapeutic target (such as an enzyme, transporter, or receptor), nor is it the subject of drug development or patient biomarker strategies[1][4][6]. No known diseases are specifically associated with SCEL-AS1, and drugs are not known to target it directly. Its classification as “non-protein coding” highlights its distinctiveness from classical therapeutic targets. ### Additional Notes on Data Quality - **is_incorrect:** true — SCEL-AS1, based on current evidence, is not a conventional druggable target (e.g., receptor, enzyme, or transporter) and does not have known disease or drug associations. It should not be considered an actionable therapeutic target as of now. - Information on specific functions or disease relevance for SCEL-AS1 is missing from the literature; most current understanding is extrapolated from the general functions of antisense lncRNAs[1][4][6]. If you meant another molecule, or if more detailed functional or disease-specific evidence for SCEL-AS1 emerges, updated literature review would be required.

Other names

SCEL antisense RNA 1SCEL-AS1SCEL antisense RNA 1 (non-protein coding)